Maravai LifeSciences Holdings Inc - ESG Rating & Company Profile powered by AI
This analysis of Maravai LifeSciences Holdings Inc incorporates information from across the internet as well as from public filings by Maravai LifeSciences Holdings Inc. Browse to the end of the page for potential risks for Maravai LifeSciences Holdings Inc based on industry, geography and size. The page displays a zero-cost Sustainability assessment for Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.0; made up of an environmental score of 5.0, social score of 6.0 and governance score of 6.9.
6.0
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
483 | Wakamoto Pharmaceutical Co Ltd | 6.1 | High |
483 | aTyr Pharma Inc | 6.1 | High |
498 | Maravai LifeSciences Holdings Inc | 6.0 | High |
498 | Cann Group Ltd | 6.0 | High |
498 | Biosynex SA | 6.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Maravai LifeSciences Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Does Maravai LifeSciences Holdings Inc disclose current and historical energy intensity?
Does Maravai LifeSciences Holdings Inc report the average age of the workforce?
Does Maravai LifeSciences Holdings Inc reference operational or capital allocation in relation to climate change?
Does Maravai LifeSciences Holdings Inc disclose its ethnicity pay gap?
Does Maravai LifeSciences Holdings Inc disclose cybersecurity risks?
Does Maravai LifeSciences Holdings Inc offer flexible work?
Does Maravai LifeSciences Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Maravai LifeSciences Holdings Inc disclose the number of employees in R&D functions?
Does Maravai LifeSciences Holdings Inc conduct supply chain audits?
Does Maravai LifeSciences Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Maravai LifeSciences Holdings Inc conduct 360 degree staff reviews?
Does Maravai LifeSciences Holdings Inc disclose the individual responsible for D&I?
Does Maravai LifeSciences Holdings Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Maravai LifeSciences Holdings Inc disclose current and / or historical scope 2 emissions?
Does Maravai LifeSciences Holdings Inc disclose water use targets?
Does Maravai LifeSciences Holdings Inc have careers partnerships with academic institutions?
Did Maravai LifeSciences Holdings Inc have a product recall in the last two years?
Does Maravai LifeSciences Holdings Inc disclose incidents of discrimination?
Does Maravai LifeSciences Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Has Maravai LifeSciences Holdings Inc issued a profit warning in the past 24 months?
Does Maravai LifeSciences Holdings Inc disclose parental leave metrics?
Does Maravai LifeSciences Holdings Inc disclose climate scenario or pathway analysis?
Does Maravai LifeSciences Holdings Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Maravai LifeSciences Holdings Inc disclose the pay ratio of women to men?
Does Maravai LifeSciences Holdings Inc support suppliers with sustainability related research and development?
Does Maravai LifeSciences Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Maravai LifeSciences Holdings Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Maravai LifeSciences Holdings Inc involved in embryonic stem cell research?
Does Maravai LifeSciences Holdings Inc disclose GHG and Air Emissions intensity?
Does Maravai LifeSciences Holdings Inc disclose its waste policy?
Does Maravai LifeSciences Holdings Inc report according to TCFD requirements?
Does Maravai LifeSciences Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Maravai LifeSciences Holdings Inc disclose energy use targets?
Does Maravai LifeSciences Holdings Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Maravai LifeSciences Holdings Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Maravai LifeSciences Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in three segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry, immunofluorescence, and glycobiology. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.